Uitgebreid zoeken

Dr. Kenneth F. Buechler is voorzitter bij Quidel Corp., lid van de American Association for Clinical Chemistry, lid van de American Chemical Society, lid van de International Federation of Clinical Chemistry & Lab Medicine en lid van The Biochemical Society. Hij zit in de Raad van Bestuur van Sotera Wireless, Inc. en TriVirum, Inc. Dr. Buechler was voorheen werkzaam als Voorzitter bij Sequenom, Inc., President & Chief Scientific Officer bij BioSite, Inc., President, Director & Chief Scientific Officer bij New Biosite, Inc., en Senior Scientist bij Hybritech, Inc. Hij was ook lid van de raad van bestuur van Adnavance Technologies, Inc., Astute Medical, Inc. en Edico Genome Corp. Hij behaalde zijn doctorale graad aan de Universiteit van Indiana en zijn doctorale graad aan de Universiteit van Indiana.

William J.
Buechler is the founder of Buechler Capital Asset Management LLC, which was founded in 2006.
He held the title of President from 2011 to 2012.
Mr. Buechler received an undergraduate degree from San Diego State University in 1976.

Ying J.
Buechler is currently the Chief Technology Officer at Ambrx, Inc. Prior to this role, Buechler held positions at aTyr Pharma, Inc. as the Director-Protein Services, at Egen, Inc. as the Vice President-Development, at Canji, Inc. as a Scientist, and at Prizm Pharmaceuticals, Inc. as a Principal.
Buechler completed their undergraduate degree at Peking University and their doctorate degree at the University of California San Diego.

Gary Buechler is Chief Commercial Officer and Chief Legal Officer of Actus Lend Lease LLC.
Prior to that, he was a Member of Kelley Drye & Warren LLP.
Mr. Buechler received an undergraduate degree from the University of Michigan and a JD from Georgetown University.

Bradley B.
Buechler is currently the Executive Director at AFA Academy.
Previously, he worked as the Chairman, President & Chief Executive Officer at Spartech LLC.